Retrieved 21 January 14, 2015 V&A/variation of Authorization determines: b. II. e. 7. b b. II. e. 2. b b. II. e. 3.2. b c B.III. B. II. e. 1. a. 3) concerning medicine: TOBI European procedure: UK/H/0361/001/II/060/G Mah: Novartis Europharm LTD is hereby amended as follows: changes to the immediate packaging of the finished product in relation to the composition which/quantitative and to its provider with regard to marketing authorisations authorised pack sizes in Italy following the mutual recognition procedure.
Inventory disposal lots already products can be kept on the market until the expiration date printed on the label of the medicinal product in accordance with art. 1, paragraph 5, of the causes of the April 14, 2014 # 371 AIFA published in Official Gazette No 101 of May 3, 2014.
Date of determination: from the day following that of its publication, to decompress, in Gazzetta Ufficiale della Repubblica Italiana.